Relationship between retinal thickness and visual acuity in eyes with retinal vein occlusion treated with dexamethasone implant

Retina

Volumn 36, Issue 6, 2016, Pages 1170-1176

  Danis, Ronald P ^a   Sadda, Srinivas ^b   Jiao, Jenny ^c   Li, Xiao Yan ^c   Whitcup, Scott M ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b DOHENY EYE INSTITUTE   (United States)

^c ALLERGAN INC   (United States)

^d JULES STEIN EYE INSTITUTE   (United States)

Author keywords

macular edema; optical coherence tomography; regression analysis; retinal thickness; retinal vein occlusion

Indexed keywords

DEXAMETHASONE; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BEST CORRECTED VISUAL ACUITY; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; INTRAVITREAL IMPLANT; MACULAR EDEMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); POST HOC ANALYSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); VISUAL ACUITY; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DOUBLE BLIND PROCEDURE; DRUG IMPLANT; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETINA; RETINAL VEIN OCCLUSION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84949844619     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000851     Document Type: Article

References (17)

1. McIntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010;117:1113-1123.
2. Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010;117:1094-1101.
3. Wong TY, Scott IU. Clinical practice. Retinal-vein occlusion. N Engl J Med 2010;363:2135-2144.
4. Noma H, Mimura T, Eguchi S. Association of inflammatory factors with macular edema in branch retinal vein occlusion. JAMA Ophthalmol 2013;131:160-165.
5. Haller J, Bandello F, Belfort R Jr, et al; for the Ozurdex GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117: 1134-1146.
6. Brown DM, Campochiaro PA, Singh RP, et al; CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1124-1133.
7. Campochiaro PA, Heier JS, Feiner L, et al; BRAVO Investigators. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1102-1112.
8. Ip MS, Scott IU, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127:1101-1114.
9. Scott IU, Ip MS, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009;127:1115-1128.
10. Haller J, Bandello F, Belfort R Jr, et al; for the OZURDEX GENEVA Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011;118:2453-2460.
11. Sadda S, Danis RP, Pappuru RR, et al. Vascular changes in eyes treated with dexamethasone intravitreal implant for macular edema after retinal vein occlusion. Ophthalmology 2013; 120:1423-1431.
12. Noma H, Funatsu H, Mimura T, et al. Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema. Retina 2011;31:2102-2108.
13. Ristau T, Keane PA, Walsh AC, et al. Relationship between visual acuity and spectral domain optical coherence tomography retinal parameters in neovascular age-related macular degeneration. Ophthalmologica 2014;231:37-44.
14. Hannouche RZ, Avila MP. Retinal thickness measurement and evaluation of natural history of the diabetic macular edema through optical coherence tomography. Arq Bras Oftalmol 2009;72:433-438.
15. Noma H, Funatsu H, Harino S, et al. Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema. Doc Ophthalmol 2011;123:83-91.
16. Scott IU, VanVeldhuisen PC, Oden NL, et al; SCORE Study Investigator Group. SCORE study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 2009; 116:504-512.
17. Scott IU, VanVeldhuisen PC, Oden NL, et al; Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care versus COrticosteroid for REtinal Vein Occlusion Study report 10. Ophthalmology 2011;118: 345-352.